Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease

Introduction: Parkinson disease (PD) results from the destruction of dopaminergic neurons in the brain. This study aimed to investigate the protective effects of natural antioxidants such as caffeic acid phenethyl ester (CAPE) to maintain these neurons. Methods: CAPE is one of the main ingredients o...

Full description

Bibliographic Details
Main Authors: Khojasteh Rahimi Jaberi, Manouchehr Safari, Vahid Semnani, Hamid Reza Sameni, Sam Zarbakhsh, Laya Ghahari
Format: Article
Language:English
Published: Iran University of Medical Sciences 2022-09-01
Series:Basic and Clinical Neuroscience
Subjects:
Online Access:http://bcn.iums.ac.ir/article-1-1857-en.html
_version_ 1827331135969951744
author Khojasteh Rahimi Jaberi
Manouchehr Safari
Vahid Semnani
Hamid Reza Sameni
Sam Zarbakhsh
Laya Ghahari
author_facet Khojasteh Rahimi Jaberi
Manouchehr Safari
Vahid Semnani
Hamid Reza Sameni
Sam Zarbakhsh
Laya Ghahari
author_sort Khojasteh Rahimi Jaberi
collection DOAJ
description Introduction: Parkinson disease (PD) results from the destruction of dopaminergic neurons in the brain. This study aimed to investigate the protective effects of natural antioxidants such as caffeic acid phenethyl ester (CAPE) to maintain these neurons. Methods: CAPE is one of the main ingredients of propolis. Intranasal administration of 1-methyl-4-phenyl-2;3;4;6-tetrahydropyridine (MPTP) was used to generate a PD model in rats. A total of 2×bone marrow stem cells (BMSCs) were injected from the tail vein. Behavioral tests, immunohistochemistry, DiI, cresyl fast violet, and TUNEL staining were used to evaluate the rats 2 weeks after treatment. Results: In all treatment groups with stem cells, the DiI staining method revealed that the cells migrated to the substantia nigra pars compacta after injection. Treatment with CAPE significantly protects dopaminergic neurons from MPTP. The highest number of tyrosine hydroxylase (TH) positive neurons was seen in the pre-CAPE+PD+stem cell (administration of CAPE, then the creation of PD, finally injection of stem cells) group. The number of TH+cells in all groups that received CAPE was significant compared to groups that received the stem cells only (P<0.001). Intranasal administration of MPTP significantly increases the number of apoptotic cells. The lowest number of apoptotic cells was in the CAPE+PD+stem cell group.  Conclusion: The results showed that the use of CAPE and stem cells in Parkinson rats caused a significant reduction in the apoptotic cells.
first_indexed 2024-03-07T16:30:36Z
format Article
id doaj.art-893916cd6fd943dcba4c42e561e4e37c
institution Directory Open Access Journal
issn 2008-126X
2228-7442
language English
last_indexed 2024-03-07T16:30:36Z
publishDate 2022-09-01
publisher Iran University of Medical Sciences
record_format Article
series Basic and Clinical Neuroscience
spelling doaj.art-893916cd6fd943dcba4c42e561e4e37c2024-03-03T11:21:51ZengIran University of Medical SciencesBasic and Clinical Neuroscience2008-126X2228-74422022-09-01135637646Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson DiseaseKhojasteh Rahimi Jaberi0Manouchehr Safari1Vahid Semnani2Hamid Reza Sameni3Sam Zarbakhsh4Laya Ghahari5 Department of Anatomy, Nervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran. Department of Anatomy, Nervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran. Department of Pathology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. Department of Anatomy, Nervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran. Department of Anatomy, Nervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran. Department of Anatomy, School of Medicine, AJA University of Medical Sciences, Tehran, Iran. Introduction: Parkinson disease (PD) results from the destruction of dopaminergic neurons in the brain. This study aimed to investigate the protective effects of natural antioxidants such as caffeic acid phenethyl ester (CAPE) to maintain these neurons. Methods: CAPE is one of the main ingredients of propolis. Intranasal administration of 1-methyl-4-phenyl-2;3;4;6-tetrahydropyridine (MPTP) was used to generate a PD model in rats. A total of 2×bone marrow stem cells (BMSCs) were injected from the tail vein. Behavioral tests, immunohistochemistry, DiI, cresyl fast violet, and TUNEL staining were used to evaluate the rats 2 weeks after treatment. Results: In all treatment groups with stem cells, the DiI staining method revealed that the cells migrated to the substantia nigra pars compacta after injection. Treatment with CAPE significantly protects dopaminergic neurons from MPTP. The highest number of tyrosine hydroxylase (TH) positive neurons was seen in the pre-CAPE+PD+stem cell (administration of CAPE, then the creation of PD, finally injection of stem cells) group. The number of TH+cells in all groups that received CAPE was significant compared to groups that received the stem cells only (P<0.001). Intranasal administration of MPTP significantly increases the number of apoptotic cells. The lowest number of apoptotic cells was in the CAPE+PD+stem cell group.  Conclusion: The results showed that the use of CAPE and stem cells in Parkinson rats caused a significant reduction in the apoptotic cells.http://bcn.iums.ac.ir/article-1-1857-en.htmlparkinson diseasemptpantioxidantcaffeic acid phenethyl estertunnel staining
spellingShingle Khojasteh Rahimi Jaberi
Manouchehr Safari
Vahid Semnani
Hamid Reza Sameni
Sam Zarbakhsh
Laya Ghahari
Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
Basic and Clinical Neuroscience
parkinson disease
mptp
antioxidant
caffeic acid phenethyl ester
tunnel staining
title Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
title_full Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
title_fullStr Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
title_full_unstemmed Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
title_short Caffeic Acid Phenethyl Ester With Mesenchymal Stem Cells Improves Behavioral and Histopathological Changes in the Rat Model of Parkinson Disease
title_sort caffeic acid phenethyl ester with mesenchymal stem cells improves behavioral and histopathological changes in the rat model of parkinson disease
topic parkinson disease
mptp
antioxidant
caffeic acid phenethyl ester
tunnel staining
url http://bcn.iums.ac.ir/article-1-1857-en.html
work_keys_str_mv AT khojastehrahimijaberi caffeicacidphenethylesterwithmesenchymalstemcellsimprovesbehavioralandhistopathologicalchangesintheratmodelofparkinsondisease
AT manouchehrsafari caffeicacidphenethylesterwithmesenchymalstemcellsimprovesbehavioralandhistopathologicalchangesintheratmodelofparkinsondisease
AT vahidsemnani caffeicacidphenethylesterwithmesenchymalstemcellsimprovesbehavioralandhistopathologicalchangesintheratmodelofparkinsondisease
AT hamidrezasameni caffeicacidphenethylesterwithmesenchymalstemcellsimprovesbehavioralandhistopathologicalchangesintheratmodelofparkinsondisease
AT samzarbakhsh caffeicacidphenethylesterwithmesenchymalstemcellsimprovesbehavioralandhistopathologicalchangesintheratmodelofparkinsondisease
AT layaghahari caffeicacidphenethylesterwithmesenchymalstemcellsimprovesbehavioralandhistopathologicalchangesintheratmodelofparkinsondisease